SAN FRANCISCO (AP) -- Prescription drug distributor McKesson Corp. said Monday that it agreed to buy Med3000, a health care management and technology service company. Med3000 helps physician groups ...
Update on a milestone year of regulatory and commercial progress for MED3000 Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its ...
MED3000 helps men get an erection within 10 minutes, faster than on-demand oral tablet phosphodiesterase-5 inhibitors ("PDE5is" - oral treatments for the treatment of ED such as Viagra® Levitra ® and ...
FM71 Trial Design FM71 is a multi-center, randomized, open-label, home use, parallel group, clinical investigation of topically-applied MED3000 gel compared to oral tadalafil (5mg) tablets for the ...
- Company also announced that it raised proceeds of £4,375,000 to fund future commercialization of MED3000 via a warrant exercise by a large institutional shareholder - GUILDFORD, England--(BUSINESS ...
Futura Announces Collaboration with Cooper Consumer Health to Commercialise MED3000 in EEA, United Kingdom and Switzerland Futura Medical plc (AIM: FUM), a pharmaceutical company developing a ...
SAN FRANCISCO (AP) -- Prescription drug distributor McKesson Corp. said Monday that it agreed to buy Med3000, a health care management and technology service company. Med3000 helps physician groups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results